Many potentially efficient drugs have been created to treat neurological disorders, but they cannot be used in practice.
Typically, for a condition such as epilepsy, it is essential to act at exactly the right time and place in the brain. For this reason, the team of researchers led by Christophe Bernard at Inserm Unit 1106, “Institute of Systems Neuroscience” (INS), with the help of scientists at the École des Mines de Saint-Étienne and Linköping University (Sweden) have developed an organic electronic micropump which, when combined with an anticonvulsant drug, enables localised inhibition of epileptic seizure in brain tissue in vitro. This research is published in the journal Advanced Materials.
Drugs constitute the most widely used approach for treating brain disorders. However, many promising drugs failed during clinical testing for several reasons:
- they are diluted in potentially toxic solutions,
- they may themselves be toxic when they reach organs to which they were not initially directed,
- the blood-brain barrier, which separates the brain from the blood circulation, prevents most drugs from reaching their targets in the brain,
- drugs that succeed in penetrating the brain will act in a non-specific manner, i.e. on healthy regions of the brain, altering their functions.
Epilepsy is a typical example of a condition for which many drugs could not be commercialised because of their harmful effects, when they might have been effective for treating patients resistant to conventional treatments .
During an epileptic seizure, the nerve cells in a specific area of the brain are suddenly activated in an excessive manner. How can this phenomenon be controlled without affecting healthy brain regions? To answer this question, Christophe Bernard’s team, in collaboration with a team led by George Malliaras at the Georges Charpak-Provence Campus of the École des Mines of Saint-Étienne and Swedish scientists led by Magnus Berggren from Linköping University, have developed a biocompatible micropump that makes it possible to deliver therapeutic substances directly to the relevant areas of the brain.
The micropump (20 times thinner than a hair) is composed of a membrane known as “cation exchange,” i.e., it has negative ions attached to its surface. It thus attracts small positively charged molecules, whether these are ions or drugs. When an electrical current is applied to it, the flow of electrons generated projects the molecules of interest toward the target area.
The Latest on: Drug delivery system
via Google News
The Latest on: Drug delivery system
- Transdermal Drug Delivery System Market Outlook and Growth Stance Forecasted Through 2025on January 9, 2020 at 10:55 pm
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry ...
- Injectable Drug Delivery Market 2020: Size, Share, Growth, Trends and Regional Forecast | Fortune Business Insights™on January 9, 2020 at 2:55 am
This further increases the adoption of injectable drug delivery systems. These manufacturers are planning to develop innovative drug delivery such as auto-injectors, smart wearables, among others in ...
- Transdermal Drug Delivery System Market Size 2020-2024 Industry Chain Structure, Key Factors, New Competitors SWOT Analysison January 7, 2020 at 12:08 am
In Transdermal Drug Delivery System market report, Global competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Novel Vaccine Delivery Devices Market, 2019-2030on January 6, 2020 at 4:01 pm
INTRODUCTIONAccording to experts, the global vaccines market is anticipated to generate revenues worth USD 100 billion by 2025. Data presented by the WHO indicates that the current global vaccination ...
- glyceryl trinitrate TRANSDERMAL DRUG DELIVERY SYSTEM SACHETon January 6, 2020 at 2:46 pm
This leaflet answers some common questions about Transiderm-Nitro. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be ...
- Self-nanoemulsifying Drug Delivery Systems: Formulation Insights, Applications and Advanceson December 27, 2019 at 4:00 pm
Self-nanoemulsifying drug delivery systems (SNEDDS) are anhydrous homogenous liquid mixtures consisting of oil, surfactant, drug and coemulsifier or solubilizer, which spontaneously form oil-in-water ...
- 3D Printing Microstructures for New Drug Delivery Systems with SPHRINTon December 20, 2019 at 12:18 am
In the recently published, ‘SPHRINT – Printing Drug Delivery Microspheres from Polymeric Melts,’ authors Tal Shpigel, Almog Uziel, and Dan Y. Lewitus explore better ways to offer sustained release ...
- A new gene therapy strategy, courtesy of natureon December 17, 2019 at 11:28 am
Because of exosomes' safe access to the brain, Lee said, this drug-delivery system has promise for future applications in neurological diseases such as Alzheimer's and Parkinson's disease. "Hopefully, ...
- United Therapeutics stalled in launching drug delivery systemon December 13, 2019 at 11:05 am
The implantable system for Remodulin would bring to patients a new intravenous delivery method for the drug — and would help United Therapeutics maintain its edge over growing threats to its top line, ...
- Global Transdermal Drug Delivery Systems Market, Outlook and Forecast 2019-2025 - ResearchAndMarkets.comon November 27, 2019 at 9:55 am
DUBLIN--(BUSINESS WIRE)--The "Transdermal Drug Delivery System Market Size, Outlook and Growth Opportunities, 2019-2025" report has been added to ResearchAndMarkets.com's offering. This report ...
via Bing News